Systems and methods for therapeutic nasal neuromodulation
The invention generally relates to systems and methods for therapeutically modulating nerves in or associated with a nasal region of a patient for the treatment of a rhinosinusitis condition.
1. A method for treating a condition within a nasal cavity of a patient, the method comprising:
advancing a device into a nasal cavity of a subject, the device comprising a multi-segment end effector for delivering energy to one or more target sites within the nasal cavity of the patient, the multi-segment end effector comprising a first segment and a second segment, wherein the first segment comprises a first set of flexible support elements and the second segment comprises a second set of flexible support elements;
deploying the first segment from a retracted configuration to a deployed configuration to fit around at least a portion of a middle turbinate at an anterior position relative to a lateral attachment and posterior-inferior edge of the middle turbinate, wherein when the first segment is in a deployed configuration, the first set of flexible support elements comprises a first pair of struts, each comprising a loop shape and extending upward, and a second pair of struts, each comprising a loop shape and extending downward such that the first set of flexible support elements conforms to and complements a shape of lateral attachment of the middle turbinate at the anterior position;
deploying the second segment from a retracted configuration to a deployed configuration to contact a plurality of tissue locations in a cavity at a posterior position relative to the lateral attachment and posterior-inferior edge of the middle turbinate, wherein when the second segment is in a deployed configuration, the second set of flexible support elements conforms to and complements a shape of at least a second anatomical structure in the cavity posterior to the middle turbinate; and
delivering energy, via the first and second segments, to tissue at one or more target sites with respect to the lateral attachment and posterior-inferior edge of the middle turbinate and the plurality of tissue locations in the cavity posterior to the middle turbinate.
2. The method of claim 1 , wherein, when in the expanded deployed configuration, the second set of flexible support elements comprises a second set of struts, each comprising a loop shape extending outward to form an open-ended circumferential shape.
3. The method of claim 1 , wherein the first and second sets of flexible support elements comprise deformable composite wires, said composite wires comprising shape memory material.
4. The method of claim 1 , wherein the first and second segments comprise first and second sets of electrodes provided thereon, respectively, the first and second sets of electrodes are configured to deliver radiofrequency (RF) energy to one or more target sites associated with parasympathetic nerve supply.
5. The method of claim 4 , wherein, when in the deployed configuration, the first and second segments position one or more of the respective first and second sets of electrodes at one or more target sites relative to the middle turbinate and the plurality of tissue locations in the cavity behind the middle turbinate.
6. The method of claim 5 , wherein delivering energy via the first and second segments comprises delivering radiofrequency (RF) energy, via one or more of the respective first and second sets of electrodes, at a level sufficient to therapeutically modulate postganglionic parasympathetic nerves innervating nasal mucosa at an innervation pathway within the nasal cavity of the patient.
7. The method of claim 6 , wherein the condition is selected from the group consisting of allergic rhinitis, non-allergic rhinitis, chronic rhinitis, acute rhinitis, chronic sinusitis, acute sinusitis, chronic rhinosinusitis, acute rhinosinusitis, and medical resistant rhinitis.
8. A method for treating a condition within a nasal cavity of a patient, the method comprising:
advancing a device into a nasal cavity of a subject, the device comprising a multi-segment end effector for delivering energy to one or more target sites within the nasal cavity of the patient, a shaft operably associated with the multi-segment end effector, wherein the multi-segment end effector comprises a first segment comprising a plurality of first support structures that each comprise one or more electrodes, the plurality of first support structures configured in a deployed configuration to extend in a first direction upward from the shaft and form a concave shape, and a plurality of second support structures that each comprise one or more electrodes, the plurality of second support structures configured in a deployed configuration to extend in a second, opposing downward direction relative to the shaft and form a concave shape, and a second segment, the second segment configured in a deployed configuration to comprise a plurality of electrodes;
deploying the first segment from a retracted configuration to a deployed configuration to fit around at least a portion of a middle turbinate at an anterior position relative to a lateral attachment and posterior-inferior edge of the middle turbinate;
deploying the second segment from a retracted configuration to a deployed configuration to contact a plurality of tissue locations in a cavity at a posterior position relative to the lateral attachment and posterior-inferior edge of the middle turbinate; and
delivering energy, via the first and second segments, to tissue at one or more target sites with respect to the lateral attachment and posterior-inferior edge of the middle turbinate and the plurality of tissue locations in the cavity posterior to the middle turbinate.
9. The method of claim 8 , wherein the plurality of first support structures comprises at least a first pair of support elements that cooperatively form the concave shape relative to the shaft in the first direction when in the deployed configuration and the plurality of second support structures comprises at least a second pair of support elements the cooperatively form the concave shape relative to the shaft in the second direction.
10. The method of claim 8 , wherein the second segment comprises a plurality of third support structures that each comprise one or more of the plurality of electrodes, the plurality of third support structures configured, in the deployed configuration to extend in a third direction relative to the shaft and cooperatively form an open-ended circumferential shape.
11. The method of claim 8 , wherein the plurality of first and second support structures and the second segment comprise deformable composite wires, said composite wires comprising shape memory material.
12. The method of claim 8 , wherein the electrodes are configured to deliver radiofrequency (RF) energy.
13. A method for treating a condition within a nasal cavity of a patient, the method comprising:
advancing a device into a nasal cavity of a subject, the device comprising a multi-segment end effector for delivering energy to one or more target sites within the nasal cavity of the patient, the multi-segment end effector comprising a first segment and a second segment, wherein the first segment comprises a first set of flexible support elements and the second segment comprises a second set of flexible support elements;
deploying the first segment from a retracted configuration to a deployed configuration to fit around at least a portion of a middle turbinate at an anterior position relative to a lateral attachment and posterior-inferior edge of the middle turbinate, wherein when the first segment is in a deployed configuration, the first set of flexible support elements conforms to and complements a shape of lateral attachment of the middle turbinate at the anterior position;
deploying the second segment from a retracted configuration to a deployed configuration to contact a plurality of tissue locations in a cavity at a posterior position relative to the lateral attachment and posterior-inferior edge of the middle turbinate, wherein when the second segment is in a deployed configuration, the second set of flexible support elements comprises a second set of struts, each comprising a loop shape extending outward to form an open-ended circumferential shape such that the second set of flexible support elements conforms to and complements a shape of at least a second anatomical structure in the cavity posterior to the middle turbinate; and
delivering energy, via the first and second segments, to tissue at one or more target sites with respect to the lateral attachment and posterior-inferior edge of the middle turbinate and the plurality of tissue locations in the cavity posterior to the middle turbinate.
14. The method of claim 13 , wherein, when in the deployed configuration, the first set of flexible support elements comprises a first pair of struts, each comprising a loop shape and extending upward and second pair of struts, each comprising a loop shape and extending downward.
15. The method of claim 13 , wherein the first and second sets of flexible support elements comprise deformable composite wires, said composite wires comprising shape memory material.
16. The method of claim 13 , wherein the first and second segments comprise first and second sets of electrodes provided thereon, respectively, the first and second sets of electrodes are configured to deliver radiofrequency (RF) energy to one or more target sites associated with parasympathetic nerve supply.
17. The method of claim 16 , wherein, when in the deployed configuration, the first and second segments position one or more of the respective first and second sets of electrodes at one or more target sites relative to the middle turbinate and the plurality of tissue locations in the cavity behind the middle turbinate.
18. The method of claim 17 , wherein delivering energy via the first and second segments comprises delivering radiofrequency (RF) energy, via one or more of the respective first and second sets of electrodes, at a level sufficient to therapeutically modulate postganglionic parasympathetic nerves innervating nasal mucosa at an innervation pathway within the nasal cavity of the patient.
19. The method of claim 18 , wherein the condition is selected from the group consisting of allergic rhinitis, non-allergic rhinitis, chronic rhinitis, acute rhinitis, chronic sinusitis, acute sinusitis, chronic rhinosinusitis, acute rhinosinusitis, and medical resistant rhinitis.